Gilead Sciences Solidifies Oncology Ambitions with Landmark Acquisition of Longtime Partner Immunomedics
Gilead Sciences has taken a definitive step toward reshaping its corporate identity with the announcement of a massive acquisition that signals a
by 
Josh Weiner
Josh Weiner